Search

Your search keyword '"K.K. Brown"' showing total 5 results
Start Over Author "K.K. Brown" Topic business
5 results on '"K.K. Brown"'

2. Does HRCT Pattern Influence the Effect of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Diseases?

Author

K.K. Brown, S.L.F. Walsh, A. Devaraj, J.W. Song, W.A. Wuyts, C. Valenzuela, R.-G. Goeldner, S. Stowasser, R. Schlenker-Herceg, A.U. Wells, and null on behalf of the INBUILD trial investigators

Subjects
medicine.medical_specialty, chemistry.chemical_compound, Lung, medicine.anatomical_structure, chemistry, business.industry, Internal medicine, Medicine, In patient, Nintedanib, business, Gastroenterology
Published
2020
Full Text
View/download PDF

3. Characteristics of Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs) in the INBUILD Trial of Nintedanib

Author

K.R. Flaherty, A.U. Wells, E. Clerisme-Beaty, V. Cottin, A. Devaraj, Y. Inoue, L. Richeldi, S. Walsh, R.-G. Goeldner, R. Schlenker-Herceg, K.K. Brown, and null on behalf of the INBUILD trial inve

Subjects
medicine.medical_specialty, chemistry.chemical_compound, Lung, medicine.anatomical_structure, chemistry, business.industry, Internal medicine, medicine, Nintedanib, business, Gastroenterology
Published
2019
Full Text
View/download PDF

4. Circulating Plasma Proteins Differentially Detected in Idiopathic Pulmonary Fibrosis and in Subjects with Pre-Clinical Pulmonary Fibrosis

Author

Mark P. Steele, Ivana V. Yang, K.K. Brown, Susan K. Mathai, Oliver Eickelberg, J.E. Loyd, Marvin I. Schwarz, Julia Powers, Jonathan Cardwell, T.E. Fingerlin, Stefanie M. Hauck, D.A. Lynch, Jonathan A. Kropski, Avram D Walts, David A. Schwartz, Fabian Metzger, and Cheryl Markin

Subjects
Pathology, medicine.medical_specialty, Idiopathic pulmonary fibrosis, business.industry, Pulmonary fibrosis, Medicine, business, medicine.disease, Blood proteins
Published
2019
Full Text
View/download PDF

5. INTERSTITIAL LUNG DISEASE | Overview

Author

G.P. Cosgrove and K.K. Brown

Subjects
medicine.medical_specialty, business.industry, Mechanism (biology), Interstitial lung disease, Disease, respiratory system, medicine.disease, respiratory tract diseases, Idiopathic pulmonary fibrosis, Pulmonary fibrosis, Pulmonary medicine, Medicine, business, Intensive care medicine
Abstract

Comprised of over 150 named disorders, interstitial lung disease (ILD) is a complex area of pulmonary medicine for generalists and experts alike. While many of the disorders share common clinical features, the mechanism of disease, outcome, type, or even availability of therapy for each specific disease often differs dramatically. An accurate diagnosis is therefore essential for the determination of prognosis and appropriate management. This article provides a framework for the classification and evaluation of patients with ILD.

Published
2006
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results